156 related articles for article (PubMed ID: 3111953)
21. [Therapy of disseminated intravascular coagulation].
Matsuda T
Rinsho Byori; 1985 Jun; Spec No 63():79-89. PubMed ID: 3930817
[No Abstract] [Full Text] [Related]
22. Treatment of disseminated intravascular coagulation with gabexate mesilate.
Tamaki S; Wada H; Hiyoyama K; Shimura M; Minamikawa K; Wakita Y; Nakase T; Ohiwa M; Kaneko T; Iwasaki E
Clin Ther; 1993; 15(6):1076-84. PubMed ID: 8111805
[TBL] [Abstract][Full Text] [Related]
23. [Studies on antithrombin III. II. The role for antithrombin III (ATIII) in the control of disseminated intravascular coagulation (DIC). (The effect of the administration of ATIII concentrates in experimental DIC and in clinical DIC) (author's transl)].
Takahashi K
Nihon Ketsueki Gakkai Zasshi; 1980 Oct; 43(5):889-97. PubMed ID: 6940410
[No Abstract] [Full Text] [Related]
24. Clinical use of antithrombin III concentrates.
Vinazzer H
Vox Sang; 1987; 53(4):193-8. PubMed ID: 3326267
[TBL] [Abstract][Full Text] [Related]
25. Studies on the effects of primary therapy for DIC following circulatory arrest.
Takemoto Y; Tanaka S; Tanabe J; Nakamura Y; Kohama A; Shibata S
Am J Hematol; 1986 Apr; 21(4):377-82. PubMed ID: 3082185
[TBL] [Abstract][Full Text] [Related]
26. Anticoagulant therapy by continuous heparin-antithrombin III infusion in newborns with disseminated intravascular coagulation.
von Kries R; Stannigel H; Göbel U
Eur J Pediatr; 1985 Jul; 144(2):191-4. PubMed ID: 4043133
[TBL] [Abstract][Full Text] [Related]
27. Application of a synthetic serine protease inhibitor in the treatment of DIC.
Kosaki G; Kambayashi J; Imaoka S
Bibl Haematol; 1983; (49):317-27. PubMed ID: 6230076
[No Abstract] [Full Text] [Related]
28. Effects of antithrombin III in patients with disseminated intravascular coagulation diagnosed by newly developed diagnostic criteria for critical illness.
Sawamura A; Gando S; Hayakawa M; Hoshino H; Kubota N; Sugano M
Clin Appl Thromb Hemost; 2009 Oct; 15(5):561-6. PubMed ID: 18840625
[TBL] [Abstract][Full Text] [Related]
29. [Heparin, low molecular weight heparin, heparinoid, and antithrombin III therapy of disseminated intravascular coagulation].
Nakagawa M
Nihon Rinsho; 1993 Jan; 51(1):87-92. PubMed ID: 7679453
[TBL] [Abstract][Full Text] [Related]
30. Antithrombin III concentrates for treatment of disseminated intravascular coagulation in children.
Hanada T; Abe T; Takita H
Am J Pediatr Hematol Oncol; 1985; 7(1):3-8. PubMed ID: 4037242
[TBL] [Abstract][Full Text] [Related]
31. Effect of antithrombin III among patients with disseminated intravascular coagulation in obstetrics: a nationwide observational study in Japan.
Iwasaki Y; Ohbe H; Shigemi D; Fushimi K; Yasunaga H
BJOG; 2022 Apr; 129(5):805-811. PubMed ID: 34545675
[TBL] [Abstract][Full Text] [Related]
32. [Synthetic protease inhibitors for the treatment of DIC].
Takahashi H
Rinsho Byori; 2011 Feb; Suppl 147():152-8. PubMed ID: 21761764
[No Abstract] [Full Text] [Related]
33. [Effective use of camostat mesilate for chronic disseminated intravascular coagulation complicated by thoracoabdominal aortic aneurysm].
Yoneda K; Amano I; Tanaka H; Yagi H; Tsukaguchi N; Morii T; Narita N
Rinsho Ketsueki; 2001 Jan; 42(1):30-4. PubMed ID: 11235131
[TBL] [Abstract][Full Text] [Related]
34. [Effect of heparin and/or antithrombin III in a model of disseminated intravascular coagulation induced by endotoxin in rabbits].
Gómez C; Páramo JA; Rocha E
Sangre (Barc); 1992 Feb; 37(1):5-10. PubMed ID: 1585238
[TBL] [Abstract][Full Text] [Related]
35. [Place of antithrombin III concentrate in the intensive care of disseminated intravascular coagulation].
Vorob'eva NA; Neporada EL; Turundaevskaia OV; Mel'nikova GN
Anesteziol Reanimatol; 2007; (2):42-4. PubMed ID: 17563999
[TBL] [Abstract][Full Text] [Related]
36. Abnormal proteolysis (DIC)--successful treatment with antithrombin III concentrate and a concentrate containing F XIII and native von Willebrand factor.
Delshammar M; Lasson A; Nilsson IM; Ohlsson K; Wallmark A; Vernersson E
J Intern Med; 1989 Jan; 225(1):21-7. PubMed ID: 2783958
[TBL] [Abstract][Full Text] [Related]
37. Treatment of disseminated intravascular coagulation and its prodromal stage with gabaxate mesilate (FOY): a multi-center trial.
Okamura T; Niho Y; Itoga T; Chiba S; Miyake M; Kotsuru M; Saito H; Ichimaru M; Hara K; Takatsuki K
Acta Haematol; 1993; 90(3):120-4. PubMed ID: 8291369
[TBL] [Abstract][Full Text] [Related]
38. Use of antithrombin concentrate in stable diffuse intravascular coagulation. A case report.
Haak HL; Stolk JC; Gratama JW; van Hulsteyn H; Briet E
Acta Haematol; 1982; 68(1):28-33. PubMed ID: 6812353
[No Abstract] [Full Text] [Related]
39. [Adequate parameters for the diagnosis of disseminated intravascular coagulation (DIC) in patients with liver diseases].
Iwabuchi S; Takatori M; Okabe K
Nihon Rinsho; 1993 Jan; 51(1):67-73. PubMed ID: 8381886
[TBL] [Abstract][Full Text] [Related]
40. [The clinical efficacy of antithrombin III concentrate in infections complicated by DIC].
Kobayashi H; Kawai S; Oshitani H; Tamakuma S; Hayasaka H; Akiyama M; Nakamura T; Hashimoto I; Sawada Y; Takebe K
Kansenshogaku Zasshi; 1985 Nov; 59(11):1121-34. PubMed ID: 3938461
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
